AAAAAA

   
Results: 1-23 |
Results: 23
PROGNOSTIC APPLICATIONS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ITS LIGAND, TRANSFORMING GROWTH-FACTOR-ALPHA
Authors: WIKSTRAND CJ BIGNER DD
Citation: Cj. Wikstrand et Dd. Bigner, PROGNOSTIC APPLICATIONS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ITS LIGAND, TRANSFORMING GROWTH-FACTOR-ALPHA, Journal of the National Cancer Institute, 90(11), 1998, pp. 799-801
THE CLASS-III VARIANT OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII) - CHARACTERIZATION AND UTILIZATION AS AN IMMUNOTHERAPEUTIC TARGETS
Authors: WIKSTRAND CJ REIST CJ ARCHER GE ZALUTSKY MR BIGNER DD
Citation: Cj. Wikstrand et al., THE CLASS-III VARIANT OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII) - CHARACTERIZATION AND UTILIZATION AS AN IMMUNOTHERAPEUTIC TARGETS, Journal of neurovirology, 4(2), 1998, pp. 148-158
IODINE-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OFPATIENTS WITH RECURRENT MALIGNANT GLIOMAS - PHASE-I TRIAL RESULTS
Authors: BIGNER DD BROWN MT FRIEDMAN AH COLEMAN RE AKABANI G FRIEDMAN HS THORSTAD WL MCLENDON RE BIGNER SH ZHAO XG PEGRAM CN WIKSTRAND CJ HERNDON JE VICK NA PALEOLOGOS N COKGOR I PROVENZALE JM ZALUTSKY MR
Citation: Dd. Bigner et al., IODINE-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OFPATIENTS WITH RECURRENT MALIGNANT GLIOMAS - PHASE-I TRIAL RESULTS, Journal of clinical oncology, 16(6), 1998, pp. 2202-2212
RESULTS OF A PHASE-I TRIAL OF PATIENTS WITH RECURRENT BRAIN-TUMORS AND PRIOR RADIATION-THERAPY TREATED WITH I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 VIA SURGICALLY CREATED RESECTION CAVITIES
Authors: COKGOR I AKABANI G BROWN MT FRIEDMAN AH COLEMAN RE FRIEDMAN HS THORSTAD WL MCLENDON RE BIGNER SH ZHAO XG PEGRAM CN WIKSTRAND CJ HERNDON JE VICK NA PALEOLOGOS N ZALUTSKY MR BIGNER DD
Citation: I. Cokgor et al., RESULTS OF A PHASE-I TRIAL OF PATIENTS WITH RECURRENT BRAIN-TUMORS AND PRIOR RADIATION-THERAPY TREATED WITH I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 VIA SURGICALLY CREATED RESECTION CAVITIES, Neurology, 50(4), 1998, pp. 52005-52005
MOLECULAR AND IMMUNOHISTOLOGIC (IHC) STUDIES ON OLIGODENDROGLIAL (O) TUMORS
Authors: MATTHEWS MR RASHEED BKA MCLENDON RE WIKSTRAND CJ BIGNER DD BIGNER SH
Citation: Mr. Matthews et al., MOLECULAR AND IMMUNOHISTOLOGIC (IHC) STUDIES ON OLIGODENDROGLIAL (O) TUMORS, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 16-16
RECEPTOR DIMERIZATION IS NOT A FACTOR IN THE SIGNALING ACTIVITY OF A TRANSFORMING VARIANT EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII)
Authors: CHU CT EVERISS KD WIKSTRAND CJ BATRA SK KUNG HJ BIGNER DD
Citation: Ct. Chu et al., RECEPTOR DIMERIZATION IS NOT A FACTOR IN THE SIGNALING ACTIVITY OF A TRANSFORMING VARIANT EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII), Biochemical journal, 324, 1997, pp. 855-861
IMPROVED TARGETING OF AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR VARIANT-III MONOCLONAL-ANTIBODY IN TUMOR XENOGRAFTS AFTER LABELING USING N-SUCCINIMIDYL 5-IODO-3-PYRIDINECARBOXYLATE
Authors: REIST CJ ARCHER GE WIKSTRAND CJ BIGNER DD ZALUTSKY MR
Citation: Cj. Reist et al., IMPROVED TARGETING OF AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR VARIANT-III MONOCLONAL-ANTIBODY IN TUMOR XENOGRAFTS AFTER LABELING USING N-SUCCINIMIDYL 5-IODO-3-PYRIDINECARBOXYLATE, Cancer research, 57(8), 1997, pp. 1510-1515
CELL-SURFACE LOCALIZATION AND DENSITY OF THE TUMOR-ASSOCIATED VARIANTOF THE EPIDERMAL GROWTH-FACTOR RECEPTOR, EGFRVIII
Authors: WIKSTRAND CJ MCLENDON RE FRIEDMAN AH BIGNER DD
Citation: Cj. Wikstrand et al., CELL-SURFACE LOCALIZATION AND DENSITY OF THE TUMOR-ASSOCIATED VARIANTOF THE EPIDERMAL GROWTH-FACTOR RECEPTOR, EGFRVIII, Cancer research, 57(18), 1997, pp. 4130-4140
INTRATHECAL I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OF PATIENTS WITH LEPTOMENINGEAL NEOPLASMS OR PRIMARY BRAIN-TUMOR RESECTION CAVITIES WITH SUBARACHNOID COMMUNICATION - PHASE-I TRIAL RESULTS
Authors: BROWN MT COLEMAN RE FRIEDMAN AH FRIEDMAN HS MCLENDON RE REIMAN R FELSBERG GJ TIEN RD BIGNER SH ZALUTSKY MR ZHAO XG WIKSTRAND CJ PEGRAM CN HERNDON JE VICK NA PALEOLOGOS N FREDERICKS RK SCHOLD SC BIGNER DD
Citation: Mt. Brown et al., INTRATHECAL I-131-LABELED ANTITENASCIN MONOCLONAL-ANTIBODY 81C6 TREATMENT OF PATIENTS WITH LEPTOMENINGEAL NEOPLASMS OR PRIMARY BRAIN-TUMOR RESECTION CAVITIES WITH SUBARACHNOID COMMUNICATION - PHASE-I TRIAL RESULTS, Clinical cancer research, 2(6), 1996, pp. 963-972
IN-VIVO GROWTH-CONDITIONS SUPPRESS THE EXPRESSION OF GANGLIOSIDE GM2 AND FAVOR THAT OF LACTO SERIES GANGLIOSIDES IN THE HUMAN GLIOMA D-54MGCELL-LINE
Authors: FREDMAN P WIKSTRAND CJ MANSSON JE REIFENBERGER G BIGNER SH RASHEED A SVENNERHOLM L BIGNER DD
Citation: P. Fredman et al., IN-VIVO GROWTH-CONDITIONS SUPPRESS THE EXPRESSION OF GANGLIOSIDE GM2 AND FAVOR THAT OF LACTO SERIES GANGLIOSIDES IN THE HUMAN GLIOMA D-54MGCELL-LINE, Glycoconjugate journal, 13(3), 1996, pp. 391-399
IMMUNOTOXINS THAT TARGET AN ONCOGENIC MUTANT EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSED IN HUMAN TUMORS
Authors: LORIMER IAJ WIKSTRAND CJ BATRA SK BIGNER DD PASTAN I
Citation: Iaj. Lorimer et al., IMMUNOTOXINS THAT TARGET AN ONCOGENIC MUTANT EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSED IN HUMAN TUMORS, Clinical cancer research, 1(8), 1995, pp. 859-864
EPIDERMAL GROWTH-FACTOR LIGAND-INDEPENDENT, UNREGULATED, CELL-TRANSFORMING POTENTIAL OF A NATURALLY-OCCURRING HUMAN MUTANT EGFRVIII GENE
Authors: BATRA SK CASTELINOPRABHU S WIKSTRAND CJ ZHU XP HUMPHREY PA FRIEDMAN HS BIGNER DD
Citation: Sk. Batra et al., EPIDERMAL GROWTH-FACTOR LIGAND-INDEPENDENT, UNREGULATED, CELL-TRANSFORMING POTENTIAL OF A NATURALLY-OCCURRING HUMAN MUTANT EGFRVIII GENE, Cell growth & differentiation, 6(10), 1995, pp. 1251-1259
TUMOR-ANTIGENS IN ASTROCYTIC GLIOMAS
Authors: KURPAD SN ZHAO XG WIKSTRAND CJ BATRA SK MCLENDON RE BIGNER DD
Citation: Sn. Kurpad et al., TUMOR-ANTIGENS IN ASTROCYTIC GLIOMAS, Glia, 15(3), 1995, pp. 244-256
PHASE-I STUDIES OF TREATMENT OF MALIGNANT GLIOMAS AND NEOPLASTIC MENINGITIS WITH I-131 RADIOLABELED MONOCLONAL-ANTIBODIES ANTI-TENASCIN 81C6 AND ANTI-CHONDROITIN PROTEOGLYCAN SULFATE ME1-14 F(AB')(2) - A PRELIMINARY-REPORT
Authors: BIGNER DD BROWN M COLEMAN RE FRIEDMAN AH FRIEDMAN HS MCLENDON RE BIGNER SH ZHAO XG WIKSTRAND CJ PEGRAM CN KERBY T ZALUTSKY MR
Citation: Dd. Bigner et al., PHASE-I STUDIES OF TREATMENT OF MALIGNANT GLIOMAS AND NEOPLASTIC MENINGITIS WITH I-131 RADIOLABELED MONOCLONAL-ANTIBODIES ANTI-TENASCIN 81C6 AND ANTI-CHONDROITIN PROTEOGLYCAN SULFATE ME1-14 F(AB')(2) - A PRELIMINARY-REPORT, Journal of neuro-oncology, 24(1), 1995, pp. 109-122
TUMOR-SPECIFIC ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR VARIANT-III MONOCLONAL-ANTIBODIES - USE OF THE TYRAMINE-CELLOBIOSE RADIOIODINATION METHOD ENHANCES CELLULAR RETENTION AND UPTAKE IN TUMOR XENOGRAFTS
Authors: REIST CJ ARCHER GE KURPAD SN WIKSTRAND CJ VAIDYANATHAN G WILLINGHAM MC MOSCATELLO DK WONG AJ BIGNER DD ZALUTSKY MR
Citation: Cj. Reist et al., TUMOR-SPECIFIC ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR VARIANT-III MONOCLONAL-ANTIBODIES - USE OF THE TYRAMINE-CELLOBIOSE RADIOIODINATION METHOD ENHANCES CELLULAR RETENTION AND UPTAKE IN TUMOR XENOGRAFTS, Cancer research, 55(19), 1995, pp. 4375-4382
MONOCLONAL-ANTIBODIES AGAINST EGFRVIII ARE TUMOR-SPECIFIC AND REACT WITH BREAST AND LUNG CARCINOMAS AND MALIGNANT GLIOMAS
Authors: WIKSTRAND CJ HALE LP BATRA SK HILL ML HUMPHREY PA KURPAD SN MCLENDON RE MOSCATELLO D PEGRAM CN REIST CJ TRAWEEK ST WONG AJ ZALUTSKY MR BIGNER DD
Citation: Cj. Wikstrand et al., MONOCLONAL-ANTIBODIES AGAINST EGFRVIII ARE TUMOR-SPECIFIC AND REACT WITH BREAST AND LUNG CARCINOMAS AND MALIGNANT GLIOMAS, Cancer research, 55(14), 1995, pp. 3140-3148
ALTERED EXPRESSION OF GANGLIOSIDE PHENOTYPES OF HUMAN GLIOMAS IN-VIVOAND IN-VITRO
Authors: WIKSTRAND CJ FREDMAN P MCLENDON RR SVENNERHOLM L BIGNER DD
Citation: Cj. Wikstrand et al., ALTERED EXPRESSION OF GANGLIOSIDE PHENOTYPES OF HUMAN GLIOMAS IN-VIVOAND IN-VITRO, Molecular and chemical neuropathology, 21(2-3), 1994, pp. 129-138
MOUSE HUMAN CHIMERIC ME1-14 ANTIBODY - GENOMIC CLONING OF THE VARIABLE REGION GENES, LINKAGE TO HUMAN CONSTANT-REGION GENES, EXPRESSION, AND CHARACTERIZATION/
Authors: BATRA SK NISWONGER ML WIKSTRAND CJ PEGRAM CN ZALUTSKY MR MORRISON SL BIGNER DD
Citation: Sk. Batra et al., MOUSE HUMAN CHIMERIC ME1-14 ANTIBODY - GENOMIC CLONING OF THE VARIABLE REGION GENES, LINKAGE TO HUMAN CONSTANT-REGION GENES, EXPRESSION, AND CHARACTERIZATION/, Hybridoma, 13(2), 1994, pp. 87-97
GENERATION AND CHARACTERIZATION OF A MOUSE HUMAN CHIMERIC ANTIBODY-DIRECTED AGAINST EXTRACELLULAR-MATRIX PROTEIN TENASCIN/
Authors: HE XM ARCHER GE WIKSTRAND CJ MORRISON SL ZALUTSKY MR BIGNER DD BATRA SK
Citation: Xm. He et al., GENERATION AND CHARACTERIZATION OF A MOUSE HUMAN CHIMERIC ANTIBODY-DIRECTED AGAINST EXTRACELLULAR-MATRIX PROTEIN TENASCIN/, Journal of neuroimmunology, 52(2), 1994, pp. 127-137
IMMUNOBIOLOGY OF MALIGNANT ASTROCYTOMAS
Authors: KURPAD SN WIKSTRAND CJ BIGNER DD
Citation: Sn. Kurpad et al., IMMUNOBIOLOGY OF MALIGNANT ASTROCYTOMAS, Seminars in oncology, 21(2), 1994, pp. 149-161
BRAIN-TUMOR WORKING GROUP-REPORT ON THE 9TH INTERNATIONAL-CONFERENCE ON BRAIN-TUMOR RESEARCH AND THERAPY
Authors: DEEN DF CHIARODO A GRIMM EA FIKE JR ISRAEL MA KUN LE LEVIN VA MARTON LJ PACKER RJ PEGG AE ROSENBLUM ML SUIT HD WALKER MD WIKSTRAND CJ WILSON CB WONG AJ YUNG WKA
Citation: Df. Deen et al., BRAIN-TUMOR WORKING GROUP-REPORT ON THE 9TH INTERNATIONAL-CONFERENCE ON BRAIN-TUMOR RESEARCH AND THERAPY, Journal of neuro-oncology, 16(3), 1993, pp. 243-272
INVESTIGATION OF A SYNTHETIC PEPTIDE AS IMMUNOGEN FOR A VARIANT EPIDERMAL GROWTH-FACTOR RECEPTOR-ASSOCIATED WITH GLIOMAS
Authors: WIKSTRAND CJ STANLEY SD HUMPHREY PA PEGRAM CN ARCHER GE KURPAD S SHIBUYA M BIGNER DD
Citation: Cj. Wikstrand et al., INVESTIGATION OF A SYNTHETIC PEPTIDE AS IMMUNOGEN FOR A VARIANT EPIDERMAL GROWTH-FACTOR RECEPTOR-ASSOCIATED WITH GLIOMAS, Journal of neuroimmunology, 46(1-2), 1993, pp. 165-174
GENERATION AND CHARACTERIZATION OF MOUSE-HUMAN CHIMERIC MEL-14 ANTIBODY
Authors: BATRA SK NISWONGER M WIKSTRAND CJ ZALUTSKY MR MORRISON SL BIGNER DD
Citation: Sk. Batra et al., GENERATION AND CHARACTERIZATION OF MOUSE-HUMAN CHIMERIC MEL-14 ANTIBODY, The Journal of immunology, 150(8), 1993, pp. 150-150
Risultati: 1-23 |